https://www.selleckchem.com/pr....oducts/Glycyrrhizic-
s reserved. This article is protected by copyright. All rights reserved.OBJECTIVE The aim of this study was to investigate whether the level, rate, and acceleration of BMI growth differ according to the presence or absence of adult cardiometabolic (CM) risks. METHODS BMI was measured in 1,000 Chileans at nine time points from birth to 23 years, and metabolic syndrome and its components were assessed at young adulthood. BMI growth was analyzed in the following three developmental periods birth to 6 months, 6 months to 5 years,